Michael T. McDermott

3.1k total citations
65 papers, 2.2k citations indexed

About

Michael T. McDermott is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Michael T. McDermott has authored 65 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Michael T. McDermott's work include Thyroid Disorders and Treatments (25 papers), Thyroid Cancer Diagnosis and Treatment (18 papers) and Growth Hormone and Insulin-like Growth Factors (13 papers). Michael T. McDermott is often cited by papers focused on Thyroid Disorders and Treatments (25 papers), Thyroid Cancer Diagnosis and Treatment (18 papers) and Growth Hormone and Insulin-like Growth Factors (13 papers). Michael T. McDermott collaborates with scholars based in United States, Australia and China. Michael T. McDermott's co-authors include E. Chester Ridgway, Gerald S. Kidd, Bryan R. Haugen, H. Jack Baskin, Lisa H. Fish, Peter Singer, Hossein Gharib, R. Michael Tuttle, Fred D. Hofeldt and Larry K. Golightly and has published in prestigious journals such as Journal of Biological Chemistry, Annals of Internal Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Michael T. McDermott

63 papers receiving 2.0k citations

Peers

Countries citing papers authored by Michael T. McDermott

Since Specialization

Citations

This map shows the geographic impact of Michael T. McDermott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. McDermott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. McDermott more than expected).

Fields of papers citing papers by Michael T. McDermott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael T. McDermott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. McDermott. The network helps show where Michael T. McDermott may publish in the future.

Co-authorship network of co-authors of Michael T. McDermott

This figure shows the co-authorship network connecting the top 25 collaborators of Michael T. McDermott. A scholar is included among the top collaborators of Michael T. McDermott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael T. McDermott. Michael T. McDermott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High‐ and normal‐protein diets improve body composition and glucose control in adults with type 2 diabetes: a randomized trial 2023 ·Obesity ·(unknown), R. Drew Sayer, Zhaoxing Pan, (unknown), Michael T. McDermott, Victoria A. Catenacci, Holly R. Wyatt, James O. Hill	7
2	Initial Management of Severe Hyperglycemia in Patients with Type 2 Diabetes: an Observational Study 2013 ·Diabetes Therapy ·W. M. King, Michael T. McDermott, Jennifer Trujillo	4
3	Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors 2012 ·Clinical Pharmacokinetics ·Larry K. Golightly, (unknown), Michael T. McDermott	138
4	Does Combination T4 And T3 Therapy Make Sense? 2012 ·Endocrine Practice ·Michael T. McDermott	9
5	Osteoporosis Risk in Premenopausal Women 2009 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Sheryl F. Vondracek, Laura Hansen, Michael T. McDermott	36
6	An Outreach Intervention Increases Bone Densitometry Testing in Older Women 2009 ·Journal of the American Geriatrics Society ·Thomas D. Denberg, (unknown), Chen‐Tan Lin, Anne M. Libby, Sung‐Joon Min, Michael T. McDermott, John F. Steiner	9
7	Palpable pediatric thyroid abnormalities – diagnostic pitfalls necessitate a high index of clinical suspicion: a case report 2007 ·Journal of Medical Case Reports ·Joshua Klopper, Michael T. McDermott	3
8	Management of Diabetes Mellitus in Hospitalized Patients: Efficiency and Effectiveness of Sliding‐Scale Insulin Therapy 2006 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Larry K. Golightly, Michael A. Jones, (unknown), Nancy M. Stolpman, Michael T. McDermott	52
9	Subclinical Thyroid Dysfunction: A Joint Statement on Management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society 2004 ·Endocrine Practice ·Hossein Gharib, R. Michael Tuttle, H. Jack Baskin, Lisa H. Fish, Peter Singer, Michael T. McDermott	57
10	Lack of Diagnosis and Treatment of Osteoporosis in Men and Women After Hip Fracture 2003 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·S Follin, (unknown), Michael T. McDermott	77
11	Management Practices Among Primary Care Physicians and Thyroid Specialists in the Care of Hypothyroid Patients 2001 ·Thyroid ·Michael T. McDermott, Bryan R. Haugen, Dennis C. Lezotte, Stacey Seggelke, E. Chester Ridgway	41
12	Subclinical Hypothyroidism Is Mild Thyroid Failure and Should be Treated 2001 ·The Journal of Clinical Endocrinology & Metabolism ·Michael T. McDermott, E. Chester Ridgway	257
13	CENTRAL HYPERTHYROIDISM 1998 ·Endocrinology and Metabolism Clinics of North America ·Michael T. McDermott, E. Chester Ridgway	26
14	Pit-1 and GATA-2 Interact and Functionally Cooperate to Activate the Thyrotropin β-Subunit Promoter 1997 ·Journal of Biological Chemistry ·David F. Gordon, (unknown), Bryan R. Haugen, Robert A. James, Michael T. McDermott, William M. Wood, E. Chester Ridgway	112
15	Determinants of Thyrotrope-specific Thyrotropin β Promoter Activation 1996 ·Journal of Biological Chemistry ·Bryan R. Haugen, Michael T. McDermott, David F. Gordon, (unknown), William M. Wood, E. Chester Ridgway	32
16	Thyroid Hormone Receptor β2 Promoter Activity in Pituitary Cells Is Regulated by Pit-1 1996 ·Journal of Biological Chemistry ·William M. Wood, Janet M. Dowding, (unknown), Michael T. McDermott, Bryan R. Haugen, David F. Gordon, E. Chester Ridgway	21
17	A longitudinal assessment of bone loss in women with levothyroxine-suppressed benign thyroid disease and thyroid cancer 1995 ·Calcified Tissue International ·Michael T. McDermott, (unknown), Gerald S. Kidd	32
18	Crossover Comparison of Maximum Dose Glyburide and Glipizide 1991 ·Southern Medical Journal ·(unknown), Michael T. McDermott, (unknown), Gerald S. Kidd	3
19	Tamoxifen Therapy for Painful Idiopathic Gynecomastia 1990 ·Southern Medical Journal ·Michael T. McDermott, Fred D. Hofeldt, Gerald S. Kidd	43
20	Effect of Hypophysectomy and Growth Hormone Administration on Hypothalamic Growth Hormone-Releasing Hormone and Somatostatin Content: Relationship to Age-Related Growth Rate 1990 ·Neuroendocrinology ·John W. Leidy, Michael T. McDermott, Richard J. Robbins	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact